8-K: Calumet, Inc. Board Chair Terminates Stock Trading Plan

Calumet, Inc. announces the termination of Board Chair Stephen Mawer's stock trading plan, which was adopted to comply with Rule 10b5-1(c) and resulted in the sale of 10,965 shares prior to termination.

Summary

• Calumet, Inc. reported that Stephen Mawer, Chair of the Board of Directors, terminated his previously disclosed stock trading plan on May 13, 2025.
• The trading plan, adopted on November 15, 2024, was intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934.
• The plan commenced on March 6, 2025, and was scheduled to expire on December 31, 2025.
• It allowed for the potential sale of up to 40,205 shares of Calumet, Inc.'s common stock.
• Prior to the termination, 10,965 shares of common stock were sold under the plan.

Sentiment

Score: 5

Explanation: The announcement is neutral, simply reporting the termination of a trading plan. It doesn't inherently suggest positive or negative implications for the company's performance.

Industry Context

The use of Rule 10b5-1 trading plans is a common practice for corporate insiders to sell shares while avoiding accusations of insider trading. The termination of such a plan can be driven by various factors, including personal financial planning or changes in the insider's outlook on the company's stock.

Stakeholder Impact

• The termination of the trading plan may have a minor impact on shareholders, depending on their perception of the reasons behind the termination and its potential effect on the stock's supply and demand.

Key Dates

Keywords

stock trading plan, Rule 10b5-1(c), Stephen Mawer, Calumet Inc., stock sale, termination